Assignee
AVA LIFESCIENCE GMBH
DE·4 granted patents·8 pending applications·5 citations·filing 2018–2023
Top patents by PatentIndex Score
12 records- 0181US11981735B2Antibodies targeting the B-cell receptor of chronic lymphocytic leukemia and uses thereofAVA LIFESCIENCE GMBH·Filed 2023·Granted May 14, 2024·1 cites·12 claims
- 0278US11644459B2Method for selecting biological binding moleculesAVA LIFESCIENCE GMBH·Filed 2019·Granted May 9, 2023·2 cites·15 claims
- 0372US11634487B2Diagnostic methodAVA LIFESCIENCE GMBH·Filed 2018·Granted Apr 25, 2023·1 cites·8 claims
- 0472US11591391B2Biological binding moleculeAVA LIFESCIENCE GMBH·Filed 2018·Granted Feb 28, 2023·1 cites·10 claims
- 0560US2023331842A1Antibodies targeting the b-cell receptor of chronic lymphocytic leukemia and uses thereofAVA LIFESCIENCE GMBH·Filed 2023·Application pending·0 cites
- 0657US2026035459A1Humanized chimeric antigen receptors targeting the b-cell receptor of chronic lymphocytic leukemia and uses thereofAVA LIFESCIENCE GMBH·Filed 2023·Application pending·0 cites
- 0750US2025145706A1Antibodies targeting the b-cell receptor of chronic lymphocytic leukemia and uses thereofAVA LIFESCIENCE GMBH·Filed 2023·Application pending·0 cites
- 0848US2021299625A1Microparticle for Bioanalytical Investigations and Method for Producing Such a MicroparticleAVA LIFESCIENCE GMBH·Filed 2021·Application pending·0 cites
- 0941US2022340978A1Method for detecting the tendency to form leukemiaAVA LIFESCIENCE GMBH·Filed 2019·Application pending·0 cites
- 1040US2022137077A1Flow Cytometry Measurement Method and Kit for Carrying Out SameAVA LIFESCIENCE GMBH·Filed 2019·Application pending·0 cites
- 1140US2022356244A1Method for selecting biological binding moleculesAVA LIFESCIENCE GMBH·Filed 2019·Application pending·0 cites
- 1240US2022227864A1Biological binding moleculesAVA LIFESCIENCE GMBH·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →